2m 2m 2m 2m 2m 2m 2m
C4 THERAPEUTICS (CCCC)
NASDAQ
$3.90-$0.02 (-0.48%)
Price as of Jul 14, 2026 6:56 AM EDT- $433.4MMarket Cap
- 64.71%1-Year Change
- BiotechnologyIndustry
C4 THERAPEUTICS (CCCC)
$3.90-$0.02 (-0.48%)
CCCC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.92 | ||
Change | -$0.14 (-3.45%) | ||
Open | $4.05 | ||
High | $4.05 | ||
Low | $3.83 | ||
Previous Close | $4.06 | ||
Volume | 3,013,353 | ||
30-Day Average Volume | 4,151,003 | ||
1-Week Change | -5.31% | ||
1-Month Change | 0.51% | ||
1-Year Change | 64.71% | ||
3-Year Change | 7.69% | ||
5-Year Change | -89.63% | ||
Fundamentals | |||
Shares Outstanding | 110.6M | ||
Total Assets | $328.9M | ||
Market Cap | $433.4M | ||
Enterprise Value | $372.1M | ||
Period: QTR TTM FY | |||
Revenue | $6.2M | ||
Net Income | -$25.1M | ||
Free Cash Flow | -$30.0M | ||
EBIT | -$25.1M | ||
EBITDA | -$24.7M | ||
Net Working Capital | $218.1M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 60 | ||
P/B | 2 | ||
P/E | -20 | ||
PEG | 1 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue